Metraipolis › archive › dc_7bb4ce81741b

Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trial — Europe PMC PMID:41614485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614485
DOI
10.1093/esj/23969873251360974
License (as archived)
solo-consultazione
Archived
2026-11-07T06:16:21.932Z
SHA-256 of the archived text
f5ac63e89b3cb54736a266f1d60c08925366c86db26d2741362ff86b003e8bb3
Stable URL of this page
https://metraipolis.com/documento/dc_7bb4ce81741b

How to cite

Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trial — Europe PMC PMID:41614485 — Europe PMC (en), https://europepmc.org/article/MED/41614485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bb4ce81741b (Metraipolis archive dc_7bb4ce81741b, sha256 f5ac63e89b3cb54736a266f1d60c08925366c86db26d2741362ff86b003e8bb3)
BibTeX
@misc{dc7bb4ce81741b,
  title = {Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trial — Europe PMC PMID:41614485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614485},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bb4ce81741b; sha256 f5ac63e89b3cb54736a266f1d60c08925366c86db26d2741362ff86b003e8bb3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614485. Agents can read the archived copy with the MCP tool read_document.